The aim of the current study is to utilize two different methodologies to estimate prevalence and burden of type 2 diabetes (T2D) and obesity among the adult population in France.
Introduction
► Rates of obesity only slightly increased in the 1980s in France, compared with more dramatic increases in neighboring countries (Maillard et al., 1999; Prentice et al., 1995) .
► Since then, however, studies have suggested that more pronounced jumps in obesity prevalence have occurred, particularly in the past 10 years (Charles et al., 2008) .
► Given the relationship between obesity and other comorbidities such as diabetes (e.g., Hussain et al., 2010) , it is important to closely monitor obesity trends to understand the best means for intervention and prevention to avoid future complications.
Objective
► The aim of the current study was to utilize two different methodologies to estimate the prevalence and burden of type 2 diabetes (T2D) and obesity among the adult population in France.
Methods

Data Source
► Two separate representative data sources were used for the adult (aged 18 and older) French population. Data from the French respondents of the EU National Health and Wellness Survey (NHWS) (N=15,051) and the OBEPI survey (N=25,286) were used.
National Health and Wellness Survey • The EU NHWS is an Internet-based survey of adults (18+ years) conducted annually in France, Germany, Italy, Spain, and the UK.
• Potential respondents were selected from the Lightspeed Research panel, an online opt-in panel. A random stratified sampling framework was instituted to ensure the final NHWS sample is representative of each country's age and gender distribution.
• A total of 63,658 invitations to participate were sent to panel members in France, with 15,051 respondents meeting eligibility criteria and completing the survey (23.6% completion rate).
OBEPI Survey
• The OBEPI survey is a mailed survey conducted by TNS-Sofres (a polling agency) every three years since 1997.
• Potential respondents were selected from a pool of households through random stratified sampling to ensure the sample is representative of the French population based on age, class, gender, occupation, region, and size of city of residence.
• A total of 36,862 adults were invited from 20,000 households, and 25,286 responded (68.6% response rate).
Measures
► Demographics. Both the NHWS and OBEPI surveys assessed demographic information including age and gender.
► Health History. Height and weight information was assessed in both surveys in order to calculate body mass index (BMI) and, subsequently, presence vs. absence of obesity (BMI ≥ 30). Additionally, self-reported diagnosis of type 2 diabetes (T2D) was also assessed, as were treatments used for T2D (insulin or oral medications).
► Health Outcomes. The NHWS also included information on health-related quality of life (using mental and physical component summary scores from the SF-12v2 instrument), overall work impairment (using the Work Productivity and Activity Impairment questionnaire), and the number of physician visits in the past six months.
Statistical Analysis
► Descriptive information was provided for each survey and was provided separately using frequencies and percentages for categorical variables, and means and standard deviations for continuous variables.
► The burden of T2D was examined by comparing those with and without type 2 diabetes on health-related quality of life, overall work impairment, and the number of physician visits, using independent-samples t-tests. 
NHWS
Results
Demographics ► From the NHWS, 44.3% of respondents from France were male and the mean age was 45.1 years (SD=15.5) (see Table 1 ). From OBEPI, 47.8% of respondents were male and the mean age was 48.2 years (SD=17.8).
► A total of 30.5% (OBEPI=31.9%) and 15.6% (OBEPI=14.5%) of the French population were estimated to be overweight and obese, respectively. A total of 4.4% (from NHWS) and 5.0% (from OBEPI) of the adult French population reported suffering from T2D.
► Among patients with T2D, 15.1% and 80.5% were taking an insulin and oral treatment, respectively (15.8% and 73.1%, respectively, as estimated by OBEPI) (see Table 2 ). ► Similarly, patients with T2D who were currently employed (n=170) reported significantly greater work impairment relative to those without T2D who were currently employed (n= 7,542) (26.7% vs. 18.2%, p<0.05). The number of physician visits was also higher among those with T2D (8.7 vs. 5.5, p<0.05). Conclusions ► Obesity and type 2 diabetes rates have been shown to have a substantial impact on the health outcomes of patients and continue to increase in their prevalence across Europe.
NHWS
► Using two different methodologies, one a mailed survey (OBEPI) and one an Internet survey (NHWS), there was a convergence in results suggesting nearly 1 in 2 French adults are either overweight or obese and nearly 5% suffer from T2D.
► The results from NHWS also suggest a significant quality of life, work productivity, and resource use burden among those with T2D in France, emphasizing the importance of addressing the rising obesity rates, which serve as an important risk factor for T2D.
► In sum, the results suggest that both the OBEPI survey and the NHWS are reliable data sources for monitoring obesity and diabetes trends in France. Given the rising prevalence of these conditions, particularly in the last decade, more emphasis should be placed on intervention strategies to alleviate long-term societal implications.
► From NHWS, a significant burden was observed among patients with T2D, as they reported significantly lower levels of physical quality of life (using the SF-12v2; 42.6 vs. 50.1, p<0.05) (see Figure 1 ). Differences in mental quality of life were not significant (45.7 vs. 46.7, p = 0.32).
